Lv4
740 积分 2022-04-17 加入
GPR119 agonists: a promising approach for T2DM treatment? A SWOT analysis of GPR119
1天前
已关闭
A Randomized-Controlled, Double-Masked Cross-Over Study of a GPR119 Agonist on Glucagon Counterregulation during Hypoglycemia in Type 1 Diabetes
2天前
已完结
Discovery of 1,4-Disubstituted Cyclohexene Analogues as Selective GPR119 Agonists for the Treatment of Type 2 Diabetes
2天前
已完结
Structural insights into the activation of G protein-coupled receptor 119 by the agonist GSK1292263 and ligands selectivity among novel cannabinoid receptors
2天前
已完结
Discovery of Fluoroalkenes as Dual Inhibitors of Diacylglycerol Kinases Alpha and Zeta (DGKα/ζ)
8天前
已完结
化学药口服改静脉注射给药非临床安全性研究评价要点
8天前
已完结
Discovery of MKP10241, a Novel Small Molecule Targeting the GPR119/Incretin Axis to Treat Metabolic Disorders
12天前
已完结
NRF2 Activation Resolves Neuropathic Pain Via Dual Antioxidant And NaV1.7-Suppressive Mechanisms
19天前
已关闭
Reducing hERG Inhibition in the Design of Potent and Bioavailable Indazole cGAS Inhibitors
28天前
已完结
Prodrugs of Carboxylic Acids
1个月前
已完结
皖公网安备34019202002308
